Researchers said NSAIDs target stem cells that lead to cancer development and cause those cells to undergo “programmed cell death” or apoptosis. The researchers studied mice with genetic defects that are similar to adenomatous polyps, which accounts for approximately 1 percent of all colorectal cancer cases. Mice that ate the NSAID in their feed showed increased rates of apoptosis within just one week.
Researchers also found NSAIDs were less effective in destroying the mutated stem cells in mice that lacked a gene called SMAC, which releases a protein during apoptosis.
Read the Science Daily news report about NSAIDs and colorectal cancer.
Read other coverage about colorectal cancer:
– Tumor Location a Factor in Colorectal Cancer Mortality
– Type 2 Diabetes and Insulin Use Connected to Higher Rate of Colorectal Cancer in Men
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
